Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$276.58M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $276.58 Million |
|---|---|
| Enterprise Value | $277.51 Million |
| Earnings per Share | $0.19 |
| Beta | 0 |
| Outstanding Shares | 20,095,314 |
Return
| Return on Equity | 4.42% |
|---|---|
| Return on Assets | 4.15% |
| Return on Invested Capital | -1.83% |
Valuation & Multiples
| P/E Ratio | 55.4 |
|---|---|
| PEG | -225.73 |
| Price to Sales | - |
| Price to Book Ratio | 1.81 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -105.38 |
| Enterprise Value to Net Income | 45 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Institutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 59.54%▼ 39.89% |
|---|---|
| Total Invested | $124.88M▼ 47.39% |
| Investors Holding | 23▼ 16.00% |
About Drugs Made In America Acquisition Corp. Ordinary Shares
2 employees
CEO: Roger Bendelac
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with...